Inactivation of Cdc42 is necessary for depolymerization of phagosomal F-actin and subsequent phagosomal maturation.
Phagocytosis is a complex process involving the activation of various signaling pathways, such as the Rho GTPases, and the subsequent reorganization of the actin cytoskeleton. In neutrophils, Rac and Cdc42 are activated during phagocytosis but less is known about the involvement of these GTPases during the different stages of the phagocytic process. The aim of this study was to elucidate the role of Cdc42 in phagocytosis and the subsequent phagosomal maturation. Using a TAT-based protein transduction technique, we introduced dominant negative and constitutively active forms of Cdc42 into neutrophil-like HL60 (human leukemia) cells that were allowed to phagocytose IgG-opsonized yeast particles. Staining of cellular F-actin in cells transduced with constitutively active Cdc42 revealed that the activation of Cdc42 induced sustained accumulation of periphagosomal actin. Moreover, the fusion of azurophilic granules with the phagosomal membrane was prevented by the accumulated F-actin. In contrast, introducing dominant negative Cdc42 impaired the translocation per se of azurophilic granules to the periphagosomal area. These results show that efficient phagosomal maturation and the subsequent eradication of ingested microbes in human neutrophils is dependent on a strictly regulated Cdc42. To induce granule translocation, Cdc42 must be in its active state but has to be inactivated to allow depolymerization of the F-actin cage around the phagosome, a process essential for phagolysosome formation.
Lerm
Maria
M
Division of Medical Microbiology, Institute for Molecular and Clinical Medicine, Faculty of Health Sciences, Linköping University, Linköping, Sweden.
Brodin
Veronika Patcha
VP
Ruishalme
Iida
I
Stendahl
Olle
O
Särndahl
Eva
E
D000199:Actins / Q000037:antagonists & inhibitors* / Q000276:immunology / Q000378:metabolism*; D003599:Cytoskeleton / Q000201:enzymology / Q000235:genetics / Q000378:metabolism; D004789:Enzyme Activation / Q000276:immunology; D004926:Escherichia coli / Q000276:immunology / Q000378:metabolism; D015696:Gene Products, tat / Q000235:genetics; D018922:HL-60 Cells; D006801:Humans; D007074:Immunoglobulin G / Q000378:metabolism / Q000502:physiology; D009504:Neutrophils / Q000201:enzymology* / Q000378:metabolism / Q000382:microbiology; D009895:Opsonin Proteins / Q000378:metabolism; D010587:Phagocytosis / Q000276:immunology; D010588:Phagosomes / Q000201:enzymology* / Q000276:immunology / Q000378:metabolism / Q000382:microbiology; D012441:Saccharomyces cerevisiae / Q000378:metabolism; D014161:Transduction, Genetic; D020764:cdc42 GTP-Binding Protein / Q000037:antagonists & inhibitors* / Q000235:genetics / Q000378:metabolism*
D000199:Actins; D015696:Gene Products, tat; D007074:Immunoglobulin G; D009895:Opsonin Proteins; D020764:cdc42 GTP-Binding Protein